229 related articles for article (PubMed ID: 23379704)
1. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Hu Y; Ren J; Zhan M; Li W; Dai H
J Travel Med; 2012 Dec; 19(6):352-6. PubMed ID: 23379704
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
DuPont HL; Jiang ZD; Okhuysen PC; Ericsson CD; de la Cabada FJ; Ke S; DuPont MW; Martinez-Sandoval F
Ann Intern Med; 2005 May; 142(10):805-12. PubMed ID: 15897530
[TBL] [Abstract][Full Text] [Related]
3. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
Martinez-Sandoval F; Ericsson CD; Jiang ZD; Okhuysen PC; Romero JH; Hernandez N; Forbes WP; Shaw A; Bortey E; DuPont HL
J Travel Med; 2010; 17(2):111-7. PubMed ID: 20412178
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season.
Flores J; Dupont HL; Jiang ZD; Okhuysen PC; Melendez-Romero JH; Gonzalez-Estrada A; Carrillo I; Paredes M
J Travel Med; 2011; 18(5):333-6. PubMed ID: 21896097
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.
Alajbegovic S; Sanders JW; Atherly DE; Riddle MS
Syst Rev; 2012 Aug; 1():39. PubMed ID: 22929178
[TBL] [Abstract][Full Text] [Related]
6. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL
Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.
Sack RB; Santosham M; Froehlich JL; Medina C; Orskov F; Orskov I
Am J Trop Med Hyg; 1984 May; 33(3):460-6. PubMed ID: 6375407
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers' diarrhea in US military personnel deployed to Incirlik Air Base, Incirlik, Turkey.
Armstrong AW; Ulukan S; Weiner M; Mostafa M; Shaheen H; Nakhla I; Tribble DR; Riddle MS
J Travel Med; 2010; 17(6):392-4. PubMed ID: 21050319
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL
Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520
[TBL] [Abstract][Full Text] [Related]
10. Rifaximin treatment of pathogen-negative travelers' diarrhea.
DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R
J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249
[TBL] [Abstract][Full Text] [Related]
11. Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis.
Fan H; Gao L; Yin Z; Ye S; Zhao H; Peng Q
Medicine (Baltimore); 2022 Oct; 101(40):e30921. PubMed ID: 36221413
[TBL] [Abstract][Full Text] [Related]
12. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
[TBL] [Abstract][Full Text] [Related]
13. Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide.
Riddle MS; Connor P; Fraser J; Porter CK; Swierczewski B; Hutley EJ; Danboise B; Simons MP; Hulseberg C; Lalani T; Gutierrez RL; Tribble DR;
Clin Infect Dis; 2017 Nov; 65(12):2008-2017. PubMed ID: 29029033
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials.
Bae JM
Epidemiol Health; 2018; 40():e2018043. PubMed ID: 30189723
[TBL] [Abstract][Full Text] [Related]
15. Bismuth subsalicylate, probiotics, rifaximin and vaccines for the prevention of travelers' diarrhea: a systematic review and network meta-analysis.
Fan H; Liu IC; Gao L; Wu L
Front Pharmacol; 2024; 15():1361501. PubMed ID: 38698820
[No Abstract] [Full Text] [Related]
16. Rifaximin: a new treatment for travelers' diarrhea.
Pakyz AL
Ann Pharmacother; 2005 Feb; 39(2):284-9. PubMed ID: 15598963
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.
Koo HL; DuPont HL
Curr Opin Gastroenterol; 2010 Jan; 26(1):17-25. PubMed ID: 19881343
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
[TBL] [Abstract][Full Text] [Related]
20. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Goldenberg JZ; Ma SS; Saxton JD; Martzen MR; Vandvik PO; Thorlund K; Guyatt GH; Johnston BC
Cochrane Database Syst Rev; 2013 May; (5):CD006095. PubMed ID: 23728658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
